Hyperfine (NASDAQ:HYPR) Trading Up 8.2% – Here’s What Happened

Hyperfine, Inc. (NASDAQ:HYPR)’s share price rose 8.2% during trading on Friday . The stock traded as high as $1.10 and last traded at $1.06. Approximately 328,884 shares were traded during trading, an increase of 6% from the average daily volume of 310,742 shares. The stock had previously closed at $0.98.

Hyperfine Stock Up 8.2 %

The company has a market capitalization of $77.33 million, a PE ratio of -1.86 and a beta of 0.86. The firm has a 50-day moving average of $0.94 and a two-hundred day moving average of $1.00.

Hyperfine (NASDAQ:HYPR) last posted its earnings results on Tuesday, November 12th. The company reported ($0.14) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.14). The firm had revenue of $3.64 million during the quarter, compared to analysts’ expectations of $3.40 million. Hyperfine had a negative net margin of 309.42% and a negative return on equity of 57.54%. During the same period in the previous year, the business posted ($0.15) EPS. Equities analysts predict that Hyperfine, Inc. will post -0.57 EPS for the current fiscal year.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Hyperfine stock. Geode Capital Management LLC boosted its stake in Hyperfine, Inc. (NASDAQ:HYPR) by 18.7% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 624,520 shares of the company’s stock after buying an additional 98,335 shares during the quarter. Geode Capital Management LLC owned approximately 0.86% of Hyperfine worth $675,000 at the end of the most recent reporting period. 15.03% of the stock is currently owned by hedge funds and other institutional investors.

About Hyperfine

Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors.